MRI: Clinical Trials

1,646 trials of MRI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

452 recruiting, 450 completed, 260 active not recruiting, 185 unknown. 444 Phase 2, 431 Not applicable, 254 Phase 1, 131 Phase 3, 36 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2444Recruiting 164, Active not recruiting 134, Completed 56, Not yet recruiting 27, Withdrawn 24, Terminated 22, Suspended 13, Enrolling by invitation 2, Unknown 2
Not applicable431Completed 170, Recruiting 88, Unknown 70, Terminated 33, Active not recruiting 31, Not yet recruiting 19, Withdrawn 17, Enrolling by invitation 2, Suspended 1
Phase 1254Recruiting 88, Active not recruiting 53, Completed 40, Terminated 24, Suspended 17, Withdrawn 15, Not yet recruiting 13, Unknown 4
Phase 3131Recruiting 57, Active not recruiting 44, Completed 10, Not yet recruiting 9, Terminated 5, Suspended 4, Unknown 1, Withdrawn 1
Early Phase 136Completed 14, Recruiting 12, Active not recruiting 4, Terminated 4, Not yet recruiting 1, Withdrawn 1
Phase 421Completed 7, Recruiting 6, Unknown 4, Terminated 2, Active not recruiting 1, Withdrawn 1

Follow MRI: new trials by email Literature Review of MRI trials Research Report on MRI

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial
Biospecimen Collection, Cisplatin, Computed Tomography - Resectable Intrahepatic Cholangiocarcinoma
Phase 2Not yet recruitingNorthwestern University442027-12-102026-06-10
Technical Development of Multi-Parametric Renocerebral MRI
MRI, Group 4 - Aging
SuspendedUniversity of Minnesota1202027-12-012026-10-14
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Biospecimen Collection, Computed Tomography, Futibatinib - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8
Phase 1Not yet recruitingNorthwestern University182027-09-092026-10-20
Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 2Not yet recruitingCity of Hope Medical Center442027-08-042026-09-10
Multi-Parametric MRI for Renal Transplantation
Magnetic Resonance Imaging - Renal Transplant Rejection
Not yet recruitingUniversity of Minnesota1402027-07-012026-09-16
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography - Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)762027-06-252026-10-22
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
Biospecimen Collection, Carboplatin, Computed Tomography - Lung Non-Squamous Non-Small Cell Carcinoma
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center162027-06-012026-02-05
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
Phase 2RecruitingChildren's Oncology Group512027-05-152026-09-24
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 1Not yet recruitingCity of Hope Medical Center362027-05-062026-09-25
Enfortumab Vedotin for the Treatment of Unresectable or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer, or NUT Carcinoma
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Differentiated Thyroid Gland Carcinoma, Metastatic NUT Carcinoma
Phase 2Not yet recruitingNorthwestern University562027-05-052026-10-07
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Plasma Cell Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)742027-04-202026-10-26
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1Not yet recruitingCity of Hope Medical Center162027-04-172026-08-11
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3RecruitingSWOG Cancer Research Network5622027-03-092026-10-13
FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma
Biospecimen Collection, Computed Tomography, Dexamethasone - Glioblastoma, Malignant Glioma
Phase 1Not yet recruitingCity of Hope Medical Center242027-02-172026-08-27
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor
Phase 2Not yet recruitingJoal Beane592027-02-152026-10-13
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
Biospecimen Collection, Bone Scan, Computed Tomography - Non-Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 3Not yet recruitingNational Cancer Institute (NCI)4002027-02-102026-07-08
SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial
Biospecimen Collection, Computed Tomography, Electronic Health Record Review - Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma
Phase 2Not yet recruitingNorthwestern University1252027-02-032026-08-06
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer
Biospecimen Collection, Cisplatin, Computed Tomography - Locally Advanced Biliary Tract Adenocarcinoma, Locally Advanced Extrahepatic Cholangiocarcinoma
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group3362027-01-112026-08-14
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer
Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group4322027-01-062026-10-01
Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Prostate Cancer
Biopsy Procedure, Computed Tomography, Electronic Health Record Review - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Not applicableNot yet recruitingCity of Hope Medical Center202027-01-012026-08-17

Showing 20 of 1646. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (107)  ·  Breast Neoplasms (87)  ·  Lung Neoplasms (59)  ·  Brain Neoplasms (51)  ·  Glioblastoma (47)  ·  Neoplasm Metastasis (43)  ·  Pancreatic Neoplasms (43)  ·  Carcinoma, Non-Small-Cell Lung (42)  ·  Glioma (42)  ·  Multiple Myeloma (33)  ·  Urinary Bladder Neoplasms (32)  ·  Carcinoma, Renal Cell (31)  ·  Carcinoma, Hepatocellular (29)  ·  Ovarian Neoplasms (29)  ·  Melanoma (28)

Sponsors

National Cancer Institute (NCI) (263)  ·  Mayo Clinic (95)  ·  City of Hope Medical Center (46)  ·  M.D. Anderson Cancer Center (45)  ·  Assiut University (37)  ·  Children's Oncology Group (28)  ·  NRG Oncology (25)  ·  University of Wisconsin, Madison (24)  ·  Jonsson Comprehensive Cancer Center (21)  ·  Memorial Sloan Kettering Cancer Center (20)  ·  Alliance for Clinical Trials in Oncology (19)  ·  Hospices Civils de Lyon (19)  ·  OHSU Knight Cancer Institute (19)  ·  University of Washington (19)  ·  Northwestern University (18)

Countries

United States (1056)  ·  France (200)  ·  Canada (119)  ·  Puerto Rico (51)  ·  United Kingdom (48)  ·  Australia (35)  ·  China (29)  ·  Switzerland (24)  ·  Germany (20)  ·  Belgium (19)  ·  Egypt (18)  ·  Netherlands (18)  ·  Denmark (17)  ·  Israel (17)  ·  Italy (17)

Top investigators

Jill N Barnes, PhD (6)  ·  Andrea B Apolo (4)  ·  Andrei Iagaru (4)  ·  Haider S Mahdi (4)  ·  Joyce F Liu (4)  ·  Rahul Aggarwal, MD (4)  ·  Roman O. Kowalchuk, MD (4)  ·  Terence C. Burns, MD, PhD (4)  ·  A P Chen (3)  ·  Behnam Badie (3)  ·  Funda Meric-Bernstam (3)  ·  Ibrahim Aldoss (3)  ·  Jacob J. Orme, MD, PhD (3)  ·  Marwan G Fakih (3)  ·  Matthew S. Block, MD, PhD (3)

Results publications

PMID 37505794, PMID 26679193, PMID 27939583, PMID 28674168, PMID 31401903, PMID 33395032, PMID 34604088, PMID 35031545, PMID 37185961, PMID 37222189, PMID 37676209, PMID 38421243, PMID 39571596, PMID 41747891, PMID 10561087, PMID 10625901, PMID 10648324, PMID 10700504, PMID 11039681, PMID 11062288, PMID 11270700, PMID 11371752, PMID 11427137, PMID 11459743, PMID 11641580, PMID 11704359, PMID 12236201, PMID 12660385, PMID 12691631, PMID 12736767, PMID 15589017, PMID 15618060, PMID 15800226, PMID 15890993, PMID 15944094, PMID 16620352, PMID 16885176, PMID 16955381, PMID 1732966, PMID 17362687, PMID 17392300, PMID 17409371, PMID 17962606, PMID 18256991, PMID 18662894, PMID 19170709, PMID 19252779, PMID 19344074, PMID 19448188, PMID 19807850

NIH funding

U10CA180868 (48), P30CA033572 (47), U10CA180820 (46), U10CA180886 (42), U10CA180821 (34), U10CA180888 (33), P30CA060553 (22), UM1CA186689 (15), UM1CA186709 (15), P30CA138292 (14), UM1CA186691 (12), P30CA014089 (11), UM1CA186644 (10), UM1CA186690 (10), UM1CA186712 (10)